HRP20171947T1 - Trisaharidni derivati i njihova upotreba kao adjuvans - Google Patents

Trisaharidni derivati i njihova upotreba kao adjuvans

Info

Publication number
HRP20171947T1
HRP20171947T1 HRP20171947TT HRP20171947T HRP20171947T1 HR P20171947 T1 HRP20171947 T1 HR P20171947T1 HR P20171947T T HRP20171947T T HR P20171947TT HR P20171947 T HRP20171947 T HR P20171947T HR P20171947 T1 HRP20171947 T1 HR P20171947T1
Authority
HR
Croatia
Prior art keywords
trisysaccharide
adjuvants
derivatives
trisysaccharide derivatives
Prior art date
Application number
HRP20171947TT
Other languages
English (en)
Croatian (hr)
Inventor
Johannes Gernardus Mathias Marie Van Bree
Everardus Joannes Peter Maria Schenkelaars
Jouwert Anne Turkstra
Maria Aldegonda Jacoba Kriek
Robert Patrick Hof
Wilhelmus Martinus Maria Schaaper
Original Assignee
Immunovo B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovo B.V. filed Critical Immunovo B.V.
Publication of HRP20171947T1 publication Critical patent/HRP20171947T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06Fatty acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
HRP20171947TT 2010-06-11 2011-06-03 Trisaharidni derivati i njihova upotreba kao adjuvans HRP20171947T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10165707A EP2397484A1 (en) 2010-06-11 2010-06-11 Trisaccharide derivates, and their use as adjuvants
EP11725217.1A EP2580226B1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants
PCT/NL2011/050393 WO2011155822A1 (en) 2010-06-11 2011-06-03 Trisaccharide derivates, and their use as adjuvants

Publications (1)

Publication Number Publication Date
HRP20171947T1 true HRP20171947T1 (hr) 2018-02-23

Family

ID=43734127

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20171947TT HRP20171947T1 (hr) 2010-06-11 2011-06-03 Trisaharidni derivati i njihova upotreba kao adjuvans

Country Status (25)

Country Link
US (2) US9327020B2 (enExample)
EP (3) EP2397484A1 (enExample)
JP (2) JP6004586B2 (enExample)
KR (1) KR101929973B1 (enExample)
CN (1) CN103154013B (enExample)
AU (1) AU2011262606B2 (enExample)
BR (1) BR112012031440A2 (enExample)
CA (1) CA2802023C (enExample)
CY (1) CY1119704T1 (enExample)
DK (1) DK2580226T3 (enExample)
ES (1) ES2654156T3 (enExample)
HR (1) HRP20171947T1 (enExample)
HU (1) HUE035187T2 (enExample)
IL (1) IL223570A (enExample)
LT (1) LT2580226T (enExample)
MX (1) MX342946B (enExample)
NO (1) NO2580226T3 (enExample)
PL (1) PL2580226T3 (enExample)
PT (1) PT2580226T (enExample)
RS (1) RS56690B1 (enExample)
RU (1) RU2595717C2 (enExample)
SI (1) SI2580226T1 (enExample)
SM (1) SMT201700603T1 (enExample)
WO (1) WO2011155822A1 (enExample)
ZA (1) ZA201209395B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants
NZ728551A (en) * 2014-07-24 2023-02-24 Litevax B V Sulphated carbohydrate fatty acid esters as vaccine adjuvants
KR20250052985A (ko) 2023-10-11 2025-04-21 세종대학교산학협력단 삼당류의 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232150A (en) * 1979-07-09 1980-11-04 American Cyanamid Company Oligosaccharide precursors to substituted O-α-D and O-β-D-multigalactopyranosyl and glucopyranosyl 1→4 and 1→6 galactopyranosyl 1→6α-D-glucopyranoses
GB8703128D0 (en) * 1987-02-11 1987-03-18 Donmarn Ltd Anti-scaling compounds
US5543505A (en) * 1993-03-15 1996-08-06 Sloan-Kettering Institute For Cancer Research Synthetic compounds which bind to H. pylori, and uses thereof
US6303120B1 (en) * 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
US5708163A (en) * 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
FI970867A7 (fi) * 1994-08-04 1997-04-08 Quadrant Drug Delivery Ltd Kiinteät, annostelusysteemit hallittua vapautumista varten, joihin sys teemeihin molekyylit on sisällytetty ja menetelmät niiden valmistamise ksi
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6517860B1 (en) * 1996-12-31 2003-02-11 Quadrant Holdings Cambridge, Ltd. Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
US6352722B1 (en) * 1997-12-23 2002-03-05 Quadrant Holdings Cambridge Limited Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
JP3041799B1 (ja) * 1998-09-29 2000-05-15 株式会社微生物化学研究所 新規なアジュバント及びそれを用いたワクチン
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
GB0124710D0 (en) * 2001-10-15 2001-12-05 Quadrant Healthcare Uk Ltd Therapeutic composition
EP1792607B1 (en) * 2005-12-01 2008-10-01 Wella Aktiengesellschaft Use of di- or oligosaccharide polyester in hair styling products
US9045516B2 (en) * 2007-04-16 2015-06-02 Suri Saranathan Iyer Synthetic ligands for the differentiation of closely related toxins and pathogens
US9242010B2 (en) * 2008-05-16 2016-01-26 Research Foundation Of The City University Of New York Living copolymer-protein/peptide hybrids for biomedical applications
WO2010087207A1 (ja) * 2009-02-02 2010-08-05 大塚化学株式会社 低分子量多硫酸化ヒアルロン酸誘導体及びこれを含有する医薬
EP2397484A1 (en) * 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
CN103154013A (zh) 2013-06-12
US20130273082A1 (en) 2013-10-17
CN103154013B (zh) 2017-03-15
ES2654156T3 (es) 2018-02-12
EP2397484A1 (en) 2011-12-21
MX2012014422A (es) 2013-08-27
RU2013100945A (ru) 2014-07-20
ZA201209395B (en) 2014-05-28
PT2580226T (pt) 2018-01-05
EP2580226A1 (en) 2013-04-17
IL223570A (en) 2017-03-30
KR101929973B1 (ko) 2018-12-18
HUE035187T2 (hu) 2018-05-02
AU2011262606A1 (en) 2013-01-10
SI2580226T1 (en) 2018-04-30
CY1119704T1 (el) 2018-06-27
MX342946B (es) 2016-10-18
CA2802023A1 (en) 2011-12-15
DK2580226T3 (en) 2018-01-08
JP2016216471A (ja) 2016-12-22
JP2013528211A (ja) 2013-07-08
RU2595717C2 (ru) 2016-08-27
KR20130056273A (ko) 2013-05-29
RS56690B1 (sr) 2018-03-30
PL2580226T3 (pl) 2018-05-30
AU2011262606B2 (en) 2016-10-27
US9327020B2 (en) 2016-05-03
WO2011155822A1 (en) 2011-12-15
EP3312188A1 (en) 2018-04-25
CA2802023C (en) 2020-07-14
NO2580226T3 (enExample) 2018-04-28
US20170057987A1 (en) 2017-03-02
LT2580226T (lt) 2018-02-26
JP6004586B2 (ja) 2016-10-12
SMT201700603T1 (it) 2018-03-08
BR112012031440A2 (pt) 2017-04-18
EP2580226B1 (en) 2017-11-29

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
SMT201600198B (it) Derivati di 1,2,4-triazina-4-ammina
IL228925A0 (en) Benzothiazole compounds and their pharmaceutical use
ME03766B (me) Određeni amino-pirimidini, njihove kompozicije, i metode njihove upotrebe
HRP20160579T1 (hr) Spoj indola i njegova farmaceutska upotreba
PL3199024T3 (pl) Zastosowanie kompozycji cyklodekstryny i stosowne sposoby
HUE042593T2 (hu) Alkoholnak ellenálló enterális gyógyszerkészítmények
BR112012031855A2 (pt) composição e artigo
EP2489334A4 (en) MEDICAL ENDOPROTHESIS
IL232262A0 (en) Therapeutic agents and uses thereof
BR112013005482A2 (pt) artigo absorvente
LT2605789T (lt) Modifikuoti relaksino polipeptidai ir jų panaudojimas
EP2529718A4 (en) VOIDABLE ARTICLE
DK2525798T3 (da) Anæstetisk formulering
HRP20171579T8 (hr) Antigljivična sredstva i njihova upotreba
DK2568890T3 (da) Femurstørrelsesbestemmelseslære
BR112012027165A2 (pt) composição e artigo
FR2956961B1 (fr) Oreiller orthopedique
EP2710926A4 (en) Simple self-assembly chair for health
EP2612610A4 (en) MEDICAL KNIFE
BR112013016108A2 (pt) artigo absorvente
CO6781486A2 (es) Compuestos y su uso
BR112014000773A2 (pt) composições de nicotinamida e uso terapêutico das mesmas
BR112013013551A2 (pt) composto e uso médico do mesmo
BR112014011135A2 (pt) composição de hidrocolóide e artigo